Wikisage, the free encyclopedia of the second generation, is digital heritage
Sjögren syndrome: Difference between revisions
Jump to navigation
Jump to search
(→Links: ref2) |
(rfz3) |
||
| Line 10: | Line 10: | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122257/ The epidemiology of Sjögren’s syndrome] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122257/ The epidemiology of Sjögren’s syndrome] | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278196/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278196/] | |||
{{Wikidata|Q335555}} | {{Wikidata|Q335555}} | ||
Revision as of 14:01, 12 March 2017
-
Karcher/PP(c)
The eponymous Sjögren syndrome is a keratoconjuntivitis sicca xerosftalmia[1] It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists, [2] affecting 0.3 - 5 % of the general population [3]
Links
Inflammation in Sjögren's syndrome: Cause or consequence?
The epidemiology of Sjögren’s syndrome
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278196/
- ↑ dictionary of medical eponyms Ediciones Roche Basle, Switzerland, p 495
- ↑ The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis
- ↑ Fox RI. Sjögren’s syndrome. Lancet. 2005;366: 321–31